Skip to content
zameds

Domperidone

Sold as Vomidon, Bio domperidone, Domperidone cipla, Motivom odt, Apex domperidone, Vomi-guard, Motilium

S4
Loading the molecular structure
C22H24ClN5O2425.90 g/mol

6-Chloro-3-[1-[3-(2-oxo-3H-benzimidazol-1-yl)propyl]piperidin-4-yl]-1H-benzimidazol-2-one

Drag to rotate. Structure from PubChem CID 3151.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
7
Registrations
9
Schedule source
Consolidated Schedules 06 July 2026

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Ranbaxy (SA) (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd1 of 2 cancelledVomidon1 mg / 1 ml, 10 mg310330, 310331S4PIPIL
Biotech Laboratories (Pty) LtdCertificate held by Biotech Laboratories (Pty) Ltd.Bio domperidone10 mg420836S4PIPIL
Cipla Medpro (Pty) LtdDomperidone ciplaNot stated520563S4None
Activo Health (Pty) LtdMotivom odt10 mg570158S4PIPIL
Austell Pharmaceuticals (Pty) LtdApex domperidone, Vomi-guard10 mg -, 10 mgA380620, A380636S4None
Johnson & Johnson (Pty) Ltd û Cape TownCertificate held by Johnson & Johnson (Pty) LtdMotilium10 mgK0261S4PIPIL
Janssen Pharmaceutica (Pty) LtdCancelledMotilium1 mg/mlV0019S4None

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Vomidon tablets

EACH TABLET CONTAINS DOMPERIDONE 10,0 mg

10 mgTablet.31033031/5.7.2/0330Approved 31 October 2022RegisteredS4PIPIL
Vomidon suspension

EACH 1,0 ml SUSPENSION CONTAINS DOMPERIDONE 1,0 mg

1 mg / 1 mlSuspension31033131/5.7.2/0331Approved 30 September 2021CancelledS4PIPIL
Bio domperidone 10

EACH TABLET CONTAINS DOMPERIDONE 10,0 mg

10 mgFilm-coated tablet42083642/5.7.2/0836Approved 28 September 2023RegisteredS4PIPIL
Domperidone cipla

Each tablet contains DOMPERIDONE 10,0 mg

Not listed52056352/5.7.2/0563RegisteredS4None
Motivom 10 odt

Each Tablet contains: Domperidone

10 mgTablet57015857/5.7.2/0158Approved 3 June 2025RegisteredS4PIPIL
Apex - domperidone 10 MG tablets

EACH TABLET CONTAINS DOMPERIDONE MALEATE EQUIVALENT TO DOMPERIDONE 10,0 mg

10 mg -TabletsA380620A38/5.7.2/0620RegisteredS4None
Vomi-guard 10 MG tablets

EACH TABLET CONTAINS DOMPERIDONE 10,0 mg

10 mgTabletsA380636A38/5.7.2/0636RegisteredS4None
Motilium

EACH TABLET CONTAINS DOMPERIDONE 10,0 mg

10 mgFilm coated tablets.K0261K/5.7.2/261Approved 12 May 2022RegisteredS4PIPIL
Motilium 1 mg/ml

EACH 1,0 ml SUSPENSION CONTAINS DOMPERIDONE 1,0 mg

1 mg/mlV0019V/5.7.2/19CancelledS4None

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Domperidone

  • S4: Domperidone

    Consolidated Schedules 06 July 2026, line 6102

Pharmacological class: Anti-emetics and antivertigo preparations. (class 5.7.2)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles